Media Summary: Joanna Chikwe MD, FRCS, FAHA, chair of the Committee on Scientific Sessions, and Brahmajee K. Nallamothu, MD, MPH, FAHA, ... As the American Heart Association's Scientific Sessions 2025 comes to a close, Chair Dr. Jo Chikwe and Vice Chair Dr. Dr. Kim Eagle and Dr. Deepak Bhatt look back on

Day3 Aha25 Highlights - Detailed Analysis & Overview

Joanna Chikwe MD, FRCS, FAHA, chair of the Committee on Scientific Sessions, and Brahmajee K. Nallamothu, MD, MPH, FAHA, ... As the American Heart Association's Scientific Sessions 2025 comes to a close, Chair Dr. Jo Chikwe and Vice Chair Dr. Dr. Kim Eagle and Dr. Deepak Bhatt look back on Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review Any way you measure the data, adds up to an outstanding event attended by thousands of surgeons. With approximately ... Day 1 of the American Heart Association's Scientific Sessions 2025 kicked off an inspiring week dedicated to advancing ...

Drs. Deepak Bhatt, Payal Kohli, and Kim Eagle discuss AHA 2025 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Erin A Bohula (Brigham ... AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying ... Day Two of AHA Sessions was nothing short of groundbreaking - a big day for science and innovation - from research ... Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829). A roundup of late breaking science news and sessions

AHA Scientific Sessions 2025 - Dr Christie Ballantyne (Baylor College of Medicine, Houston, TX, US) discusses findings from the ... Professor Clyde Yancy (Northwestern University, US) joins us to explore the future trajectory of heart failure management, ... Join this channel to get access to perks: access to ppt and ... Should non-culprit lesions be revascularized in STEMI and NSTEMI? Should revascularization of non-culprit lesions occur in a ...

Photo Gallery

DAY3 AHA25 Highlights
DAY3 AHA25 Highlights CUTDOWN
#AHA25 Day Three Highlights
#AHA25 Meeting Highlights
Day 3 Highlights | AHA 2020
Day 3 Highlights | AHA 2022
Day 3 Recap Video from the 2025 AAHKS Annual Meeting
DAY1 AHA25 Highlights Package
Day 3 Highlights | AHA 2021
AHA 25: VESALIUS-CV: Evolocumab in High-Risk Patients Without Prior MI
AHA 25: HFpEF as an Adipose Tissue Disorder: Implications for Diagnosis and Therapy
DAY2 AHA25 Highlights
Sponsored
Sponsored
View Detailed Profile
DAY3 AHA25 Highlights

DAY3 AHA25 Highlights

Watch the

DAY3 AHA25 Highlights CUTDOWN

DAY3 AHA25 Highlights CUTDOWN

Watch the

Sponsored
#AHA25 Day Three Highlights

#AHA25 Day Three Highlights

Joanna Chikwe MD, FRCS, FAHA, chair of the Committee on Scientific Sessions, and Brahmajee K. Nallamothu, MD, MPH, FAHA, ...

#AHA25 Meeting Highlights

#AHA25 Meeting Highlights

As the American Heart Association's Scientific Sessions 2025 comes to a close, Chair Dr. Jo Chikwe and Vice Chair Dr.

Day 3 Highlights | AHA 2020

Day 3 Highlights | AHA 2020

Dr. Kim Eagle and Dr. Deepak Bhatt look back on

Sponsored
Day 3 Highlights | AHA 2022

Day 3 Highlights | AHA 2022

Drs. Deepak Bhatt, Kim Eagle and Payal Kohli review

Day 3 Recap Video from the 2025 AAHKS Annual Meeting

Day 3 Recap Video from the 2025 AAHKS Annual Meeting

Any way you measure the data, #AAHKS2025 adds up to an outstanding event attended by thousands of surgeons. With approximately ...

DAY1 AHA25 Highlights Package

DAY1 AHA25 Highlights Package

Day 1 of the American Heart Association's Scientific Sessions 2025 kicked off an inspiring week dedicated to advancing ...

Day 3 Highlights | AHA 2021

Day 3 Highlights | AHA 2021

Drs. Deepak Bhatt, Payal Kohli, and Kim Eagle discuss

AHA 25: VESALIUS-CV: Evolocumab in High-Risk Patients Without Prior MI

AHA 25: VESALIUS-CV: Evolocumab in High-Risk Patients Without Prior MI

AHA 2025 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Erin A Bohula (Brigham ...

AHA 25: HFpEF as an Adipose Tissue Disorder: Implications for Diagnosis and Therapy

AHA 25: HFpEF as an Adipose Tissue Disorder: Implications for Diagnosis and Therapy

AHA Scientific Sessions 2025 - Dr Milton Packer (Baylor University Medical Center, US) joins us to discuss his novel unifying ...

DAY2 AHA25 Highlights

DAY2 AHA25 Highlights

Day Two of AHA Sessions was nothing short of groundbreaking - a big day for science and innovation - from research ...

AHA 25: The OCEAN Trial: Ongoing Oral Anticoagulation After Catheter Ablation of AF

AHA 25: The OCEAN Trial: Ongoing Oral Anticoagulation After Catheter Ablation of AF

Dr Atul Verma (McGill University Health Centre, Montreal, CA) joins us to share outcomes from OCEAN (NCT02168829).

#AHA21 Day Three Highlights

#AHA21 Day Three Highlights

A roundup of late breaking science news and sessions

AHA 25: CORALreef HeFH: Oral PCSK9 Inhibitor for Familial Hypercholesterolemia

AHA 25: CORALreef HeFH: Oral PCSK9 Inhibitor for Familial Hypercholesterolemia

AHA Scientific Sessions 2025 - Dr Christie Ballantyne (Baylor College of Medicine, Houston, TX, US) discusses findings from the ...

AHA 25: The Future of HF: Prevention, Precision Medicine, and the Changing Role of the Cardiologist

AHA 25: The Future of HF: Prevention, Precision Medicine, and the Changing Role of the Cardiologist

Professor Clyde Yancy (Northwestern University, US) joins us to explore the future trajectory of heart failure management, ...

AACE TV Day 3 #AACE2026

AACE TV Day 3 #AACE2026

That's a wrap! Check out the

3.Cardiac arrest algorithm (AHA 2025)

3.Cardiac arrest algorithm (AHA 2025)

Join this channel to get access to perks: https://www.youtube.com/channel/UCyNbj_udrZ1o1o7Ywi36ttQ/join access to ppt and ...

2025 ACC/AHA Acute Coronary Syndrome Guidelines

2025 ACC/AHA Acute Coronary Syndrome Guidelines

Should non-culprit lesions be revascularized in STEMI and NSTEMI? Should revascularization of non-culprit lesions occur in a ...